In the new report, Forrester adjusts its March analysis of digital tech providers and health insurers should consider, taking the pandemic’s effect on innovation into account.
Here are the three technologies Forrester moved from its “experiment” to “invest” stage because of advancements in response to the pandemic:
1. At-home diagnostics
2. Remote clinical monitoring
3. Wearables
Here are the remaining digital technologies Forrester recommends as a high business value investment:
1. Conversational interface
2. Digital therapeutics
3. Personal health record
4. Pharmacogenomics
5. Secure messaging/notifications
6. Self-triage
7. Virtual care
More articles on digital transformation:
Where Providence Ventures is investing millions — 17 portfolio companies
NIH boosts genomics initiatives with $75M funding
VR video preps medical staffs in remote areas for COVID-19 surges
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
